374 related articles for article (PubMed ID: 15485501)
1. A role for semaphorin 3A signaling in the degeneration of hippocampal neurons during Alzheimer's disease.
Good PF; Alapat D; Hsu A; Chu C; Perl D; Wen X; Burstein DE; Kohtz DS
J Neurochem; 2004 Nov; 91(3):716-36. PubMed ID: 15485501
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology.
Maurage CA; Sergeant N; Ruchoux MM; Hauw JJ; Delacourte A
Acta Neuropathol; 2003 Feb; 105(2):89-97. PubMed ID: 12536218
[TBL] [Abstract][Full Text] [Related]
3. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
4. Calcium-binding protein secretagogin-expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease.
Attems J; Preusser M; Grosinger-Quass M; Wagner L; Lintner F; Jellinger K
Neuropathol Appl Neurobiol; 2008 Feb; 34(1):23-32. PubMed ID: 17961140
[TBL] [Abstract][Full Text] [Related]
5. Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease.
Bondareff W; Wischik CM; Novak M; Roth M
Am J Pathol; 1991 Sep; 139(3):641-7. PubMed ID: 1909492
[TBL] [Abstract][Full Text] [Related]
6. Immunopositivity for ESCRT-III subunit CHMP2B in granulovacuolar degeneration of neurons in the Alzheimer's disease hippocampus.
Yamazaki Y; Takahashi T; Hiji M; Kurashige T; Izumi Y; Yamawaki T; Matsumoto M
Neurosci Lett; 2010 Jun; 477(2):86-90. PubMed ID: 20420883
[TBL] [Abstract][Full Text] [Related]
7. Increased tau accumulation in senile plaques as a hallmark in Alzheimer's disease.
Shin RW; Ogomori K; Kitamoto T; Tateishi J
Am J Pathol; 1989 Jun; 134(6):1365-71. PubMed ID: 2502927
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer's disease.
Lee HG; Ogawa O; Zhu X; O'Neill MJ; Petersen RB; Castellani RJ; Ghanbari H; Perry G; Smith MA
Acta Neuropathol; 2004 Apr; 107(4):365-71. PubMed ID: 14872255
[TBL] [Abstract][Full Text] [Related]
9. Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer's disease and tauopathies to granulovacuolar degeneration bodies.
Lagalwar S; Berry RW; Binder LI
Acta Neuropathol; 2007 Jan; 113(1):63-73. PubMed ID: 17089132
[TBL] [Abstract][Full Text] [Related]
10. Age-related accumulation of Reelin in amyloid-like deposits.
Knuesel I; Nyffeler M; Mormède C; Muhia M; Meyer U; Pietropaolo S; Yee BK; Pryce CR; LaFerla FM; Marighetto A; Feldon J
Neurobiol Aging; 2009 May; 30(5):697-716. PubMed ID: 17904250
[TBL] [Abstract][Full Text] [Related]
11. Nerve growth factor, glial cell line-derived neurotrophic factor and neurturin prevent semaphorin 3A-mediated growth cone collapse in adult sensory neurons.
Wanigasekara Y; Keast JR
Neuroscience; 2006 Oct; 142(2):369-79. PubMed ID: 16876331
[TBL] [Abstract][Full Text] [Related]
12. nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease.
Thorns V; Hansen L; Masliah E
Exp Neurol; 1998 Mar; 150(1):14-20. PubMed ID: 9514829
[TBL] [Abstract][Full Text] [Related]
13. Decreased estrogen receptor-alpha expression in hippocampal neurons in relation to hyperphosphorylated tau in Alzheimer patients.
Hu XY; Qin S; Lu YP; Ravid R; Swaab DF; Zhou JN
Acta Neuropathol; 2003 Sep; 106(3):213-20. PubMed ID: 12819990
[TBL] [Abstract][Full Text] [Related]
14. Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway?
Lee HG; Ueda M; Zhu X; Perry G; Smith MA
J Neurosci Res; 2006 Dec; 84(8):1856-61. PubMed ID: 16998902
[TBL] [Abstract][Full Text] [Related]
15. Signaling of the neurotrophin receptor p75 in relation to Alzheimer's disease.
Diarra A; Geetha T; Potter P; Babu JR
Biochem Biophys Res Commun; 2009 Dec; 390(3):352-6. PubMed ID: 19818333
[TBL] [Abstract][Full Text] [Related]
16. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease.
Fuentealba RA; Farias G; Scheu J; Bronfman M; Marzolo MP; Inestrosa NC
Brain Res Brain Res Rev; 2004 Dec; 47(1-3):275-89. PubMed ID: 15572177
[TBL] [Abstract][Full Text] [Related]
18. Hippocampal neurons in pre-clinical Alzheimer's disease.
West MJ; Kawas CH; Stewart WF; Rudow GL; Troncoso JC
Neurobiol Aging; 2004 Oct; 25(9):1205-12. PubMed ID: 15312966
[TBL] [Abstract][Full Text] [Related]
19. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.
Fulga TA; Elson-Schwab I; Khurana V; Steinhilb ML; Spires TL; Hyman BT; Feany MB
Nat Cell Biol; 2007 Feb; 9(2):139-48. PubMed ID: 17187063
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease.
Zhu X; McShea A; Harris PL; Raina AK; Castellani RJ; Funk JO; Shah S; Atwood C; Bowen R; Bowser R; Morelli L; Perry G; Smith MA
J Neurosci Res; 2004 Mar; 75(5):698-703. PubMed ID: 14991845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
